Key result
PFO device removal and extended antibiotics successfully resolve early S. agalactiae endocarditis.
Why the study?
Infective endocarditis following atrial septal device insertion is uncommon, and patent foramen ovale device-associated endocarditis caused by Streptococcus agalactiae complicated by endogenous endophthalmitis is a rare presentation requiring clinical guidance.
Case Report (n=1)
Highlights a rare presentation of Streptococcus agalactiae PFO closure device-associated endocarditis complicated by endogenous endophthalmitis requiring prompt device removal and multidisciplinary care.
Answers are grounded in this paper and cite their sources.
May support device removal plus antibiotics in rare PFO closure endocarditis with endophthalmitis; leaves open optimal prevention strategies.
Background: The development of infective endocarditis (IE) following the insertion of atrial septal devices is a known but uncommon complication. This case reports a rare combination of patent foramen ovale (PFO) device-associated endocarditis caused by Streptococcus agalactiae, complicated by the development of endogenous endophthalmitis (EE). This study aims to aid clinicians in both their assessment and management of acutely unwell patients presenting following implantation of PFO closure devices.Case Description: A 43-year-old female presented 9 days following a transcatheter implantation of an Amplatzer PFO closure device. The transoesophageal echocardiogram (TOE) revealed two echogenic mobile vegetations on the device, with blood cultures revealing S. agalactiae as the causative organism, confirming the diagnosis of PFO device-associated endocarditis. The patient’s presentation was subsequently complicated by the development of right-sided EE. Management involved removal of the infected device, intravitreal antibiotics, and an extended course of intravenous antibiotics. This patient improved and was discharged with outpatient follow-up arranged with the cardiology and ophthalmology teams.Conclusions: The outcome of this case highlights the importance of timely multidisciplinary team involvement, all of whom were vital to the successful management of this patient. Cardiology formally diagnosed and removed the infected device, ophthalmology recognised and treated the EE, and microbiology ensured targeted antimicrobial therapy was commenced.
No takes yet. Share an insight, caveat, or question.
Panacer et al. (2026) conducted a case report in Patent foramen ovale closure device-associated infective endocarditis caused by Streptococcus agalactiae complicated by endogenous endophthalmitis (n=1). Device removal, intravitreal antibiotics, and extended intravenous antibiotics was evaluated on Clinical improvement and discharge. Removal of the infected PFO closure device alongside intravitreal and extended IV antibiotics successfully treated a 43-year-old female presenting 9 days post-implantation with S. agalactiae endocarditis.
Synapse has enriched 10 related papers. Consider them for comparative context: